Lung Kee Group Holdings Limited (Stock Code: 00255) announced its monthly return for January 2026. The authorized share capital remained at HKD100,000,000, comprising 1,000,000,000 ordinary shares at a par value of HKD0.1 each. By the end of the month, the total number of issued shares remained at 633,887,303, with no changes in treasury shares. The public float requirement remained in compliance with the prescribed threshold.

Regarding share options, three schemes were listed without any new issuance or cancellation during January. The first scheme had 1,400,000 options outstanding at an exercise price of HKD1.578, the second had 290,000 options outstanding at an exercise price of HKD1.18, and the third had 3,000,000 options outstanding at an exercise price of HKD1.66. No warrants, convertibles, or other arrangements for additional share issuance were reported during the period.